Related references
Note: Only part of the references are listed.Second primary malignancy in myelofibrosis patients treated with ruxolitinib
Nicola Polverelli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
IL-33/IL-31 Axis in Osteoporosis
Massimo De Martinis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Ixazomib Improves Bone Remodeling and Counteracts Sonic Hedgehog Signaling Inhibition Mediated by Myeloma Cells
Daniele Tibullo et al.
CANCERS (2020)
Management of myelofibrosis after ruxolitinib failure
Claire N. Harrison et al.
ANNALS OF HEMATOLOGY (2020)
Myelofibrosis biology and contemporary management
Naseema Gangat et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Immunoproteasome Genes Are Modulated in CD34(+) JAK2(V617F) Mutated Cells from Primary Myelofibrosis Patients
Michelino Di Rosa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN
Helene F. E. Gleitz et al.
BLOOD (2020)
The Role of Inflammation and Inflammasome in Myeloproliferative Disease
Lucia Longhitano et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Vitamin D receptor-mediated skewed differentiation of macrophages initiates myelofibrosis and subsequent osteosclerosis
Kanako Wakahashi et al.
BLOOD (2019)
Myelofibrosis osteoclasts are clonal and functionally impaired
Ivo Veletic et al.
BLOOD (2019)
Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib
Francesca Palandri et al.
HEMATOLOGICAL ONCOLOGY (2019)
Clobetasol Modulates Adult Neural Stem Cell Growth via Canonical Hedgehog Pathway Activation
Nunzio Vicario et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib
Aaron T. Gerds et al.
LEUKEMIA RESEARCH (2019)
Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures
Waihay J. Wong et al.
PLOS ONE (2019)
The Role of New Technologies in Myeloproliferative Neoplasms
Giuseppe A. Palumbo et al.
FRONTIERS IN ONCOLOGY (2019)
Activation of JAK/STAT Signaling in Megakaryocytes Sustains Myeloproliferation In Vivo
Brittany Woods et al.
CLINICAL CANCER RESEARCH (2019)
The role of cellular senescence in diabetes mellitus and osteoporosis: molecular pathways and potential interventions
Georgios Giovos et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2019)
mTOR Links Tumor Immunity and Bone Metabolism: What are the Clinical Implications?
Azzurra Irelli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib
Elena Maria Elli et al.
FRONTIERS IN ONCOLOGY (2019)
THE CRUCIAL ROLE OF THE WNT SYSTEM IN BONE REMODELLING
D. Grigorie et al.
ACTA ENDOCRINOLOGICA-BUCHAREST (2018)
JAK2 exon 12 mutated polycythemia vera: Mayo-Careggi MPN Alliance study of 33 consecutive cases and comparison with JAK2V617F mutated disease
Ayalew Tefferi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
The identification of fibrosis-driving myofibroblast precursors reveals new therapeutic avenues in myelofibrosis
Rafael Kramann et al.
BLOOD (2018)
Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients
Nicola Polverelli et al.
HEMATOLOGICAL ONCOLOGY (2018)
Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis
Moo-Kon Song et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Primary myelofibrosis: 2019 update on diagnosis, risk-stratification and management
Ayalew Tefferi
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Durability of spleen response affects the outcome of ruxolitinib-treated patients with myelofibrosis: Results from a multicentre study on 284 patients
Francesca Palandri et al.
LEUKEMIA RESEARCH (2018)
The genetic association between osteoprotegerin (OPG) gene polymorphisms and bone mineral density (BMD) in postmenopausal women A meta-analysis
Yuqin Peng et al.
MEDICINE (2018)
Osteolytic Lesions in Primary Myelofibrosis and Effect of Ruxolitinib Therapy: Report of a Case and Literature Review
Cristina Bucelli et al.
CHEMOTHERAPY (2018)
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
William Vainchenker et al.
BLOOD (2017)
Mass cytometry analysis reveals hyperactive NF Kappa B signaling in myelofibrosis and secondary acute myeloid leukemia
D. A. C. Fisher et al.
LEUKEMIA (2017)
Energy Metabolism of the Osteoblast: Implications for Osteoporosis
Wen-Chih Lee et al.
ENDOCRINE REVIEWS (2017)
Somatic mutations of calreticulin in myeloproliferative neoplasms
Misa Imai et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
Leptin-receptor-expressing bone marrow stromal cells are myofibroblasts in primary myelofibrosis
Matthew Decker et al.
NATURE CELL BIOLOGY (2017)
The role of the extracellular matrix in primary myelofibrosis
O. Leiva et al.
BLOOD CANCER JOURNAL (2017)
Combination of Collagen-Based Scaffold and Bioactive Factors Induces Adipose-Derived Mesenchymal Stem Cells Chondrogenic Differentiation In vitro
Giovanna Calabrese et al.
FRONTIERS IN PHYSIOLOGY (2017)
Gli1+ Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target
Rebekka K. Schneider et al.
CELL STEM CELL (2017)
Canonical Wnt/β-Catenin Signaling Pathway Is Dysregulated in Patients With Primary and Secondary Myelofibrosis
Marko Lucijanic et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2016)
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
S. Koschmieder et al.
LEUKEMIA (2016)
Thrombopoietin/TGF-1 Loop Regulates Megakaryocyte Extracellular Matrix Component Synthesis
Vittorio Abbonante et al.
STEM CELLS (2016)
Potential Therapeutic Applications of Adipose-Derived Mesenchymal Stem Cells
Debora Lo Furno et al.
STEM CELLS AND DEVELOPMENT (2016)
Bone augmentation after ectopic implantation of a cell-free collagen-hydroxyapatite scaffold in the mouse
Giovanna Calabrese et al.
SCIENTIFIC REPORTS (2016)
Making sense of hematopoietic stem cell niches
Philip E. Boulais et al.
BLOOD (2015)
Bone geometry, bone mineral density, and micro-architecture in patients with myelofibrosis: a cross-sectional study using DXA, HR-pQCT, and bone turnover markers
Sarah Farmer et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2015)
Macrophages: Their Emerging Roles in Bone
Benjamin P. Sinder et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Role of Endothelin-1 in a Syndrome of Myelofibrosis and Osteosclerosis
Ralph Yachoui et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms
Vladan P. Cokic et al.
MEDIATORS OF INFLAMMATION (2015)
Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis
Christophe Desterke et al.
MEDIATORS OF INFLAMMATION (2015)
Fibrogenesis in Primary Myelofibrosis: Diagnostic, Clinical, and Therapeutic Implications
Aziz Nazha et al.
ONCOLOGIST (2015)
JAK-STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response
Maria Kleppe et al.
CANCER DISCOVERY (2015)
Myeloproliferative Disorders
Brian Meier et al.
EMERGENCY MEDICINE CLINICS OF NORTH AMERICA (2014)
Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union
Odile Moulard et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
The bone marrow niche for haematopoietic stem cells
Sean J. Morrison et al.
NATURE (2014)
Myeloproliferative Neoplasia Remodels the Endosteal Bone Marrow Niche into a Self-Reinforcing Leukemic Niche
Koen Schepers et al.
CELL STEM CELL (2013)
The hematopoietic stem cell niche-home for friend and foe?
Daniela S. Krause et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2013)
The Osteocyte: An Endocrine Cell . . . and More
Sarah L. Dallas et al.
ENDOCRINE REVIEWS (2013)
AKT is a therapeutic target in myeloproliferative neoplasms
I. Khan et al.
LEUKEMIA (2013)
Synergism between fibronectin and transforming growth factor-β1 in the production of substance P in monocytes of patients with myelofibrosis
Victor T. Chang et al.
LEUKEMIA & LYMPHOMA (2013)
Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?
Hans Carl Hasselbalch
LEUKEMIA RESEARCH (2013)
One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience
Ayalew Tefferi et al.
MAYO CLINIC PROCEEDINGS (2012)
Induction of Osteogenesis in Mesenchymal Stem Cells by Activated Monocytes/Macrophages Depends on Oncostatin M Signaling
Pierre Guihard et al.
STEM CELLS (2012)
Osteal Macrophages Promote In Vivo Intramembranous Bone Healing in a Mouse Tibial Injury Model
Kylie A. Alexander et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice
Matthew J. Christopher et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche
Andrew Chow et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
HOW TO MANAGE ... How I treat splenomegaly in myelofibrosis
F. Cervantes
BLOOD CANCER JOURNAL (2011)
Bone and bone marrow: The same organ
Andrea Del Fattore et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Mechanisms and functions of p38 MAPK signalling
Ana Cuadrado et al.
BIOCHEMICAL JOURNAL (2010)
Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs
Ingrid G. Winkler et al.
BLOOD (2010)
Myelofibrosis with massive hepatosplenomegaly and osteolytic bone lesions
Ginger M. Merry et al.
Journal of Hospital Medicine (2010)
The endosteal 'osteoblastic' niche and its role in hematopoietic stem cell homing and mobilization
J-P Levesque et al.
LEUKEMIA (2010)
Engraftment and Reconstitution of Hematopoiesis Is Dependent on VEGFR2-Mediated Regeneration of Sinusoidal Endothelial Cells
Andrea T. Hooper et al.
CELL STEM CELL (2009)
CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis
Claudio Tripodo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Functions of RANKL/RANK/OPG in bone modeling and remodeling
Brendan F. Boyce et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
Receptor activator of nuclear factor kappa B ligand and osteoprotegerin regulation of bone remodeling in health and disease
Ann E. Kearns et al.
ENDOCRINE REVIEWS (2008)
Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo
Ming K. Chang et al.
JOURNAL OF IMMUNOLOGY (2008)
NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells
Shuting Bai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment
Benedetto Sacchetti et al.
CELL (2007)
Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis
Joris Andrieux et al.
CANCER GENETICS AND CYTOGENETICS (2007)
Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis
Stefan O. Ciurea et al.
BLOOD (2007)
Expression of bone morphogenetic proteins and their receptors in the bone marrow megakaryocytes of GATA-1low mice:: A possible role in osteosclerosis
Rama Garimella et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2007)
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Hiroshi Takayanagi
NATURE REVIEWS IMMUNOLOGY (2007)
MPLW515L is anovel somatic activating mutation in myelofibrosis with myeloid metaplasia
Yana Pikman et al.
PLOS MEDICINE (2006)
Role of transforming growth factor-β in hematologic malignancies
Mei Dong et al.
BLOOD (2006)
Monocyte/macrophage dysfunctions do not impair the promotion of myelofibrosis by high levels of thrombopoietin
Orianne Wagner-Ballon et al.
JOURNAL OF IMMUNOLOGY (2006)
Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells
Orit Kollet et al.
NATURE MEDICINE (2006)
The stem cell niches in bone
T Yin et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor
GB Adams et al.
NATURE (2006)
RANKL-RANK signaling in osteoclastogenesis and bone disease
T Wada et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Osteosclerosis in advanced chronic idiopathic myelofibrosis is associated with endothelial overexpression of osteoprotegerin
O Bock et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells
MJ Kiel et al.
CELL (2005)
Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation
DA Glass et al.
DEVELOPMENTAL CELL (2005)
IL-8 and its CXCR1 and CXCR2 receptors participate in the control of megakaryocytic proliferation, differentiation, and ploidy in myeloid metaplasia with myelofibrosis
S Emadi et al.
BLOOD (2005)
Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin
MF Pera et al.
JOURNAL OF CELL SCIENCE (2004)
Osteosclerosis in idiopathic myelofibrosis is related to the overproduction of osteoprotegerin (OPG)
JC Wang et al.
EXPERIMENTAL HEMATOLOGY (2004)
Osteoblastic cells regulate the haematopoietic stem cell niche
LM Calvi et al.
NATURE (2003)
Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO
C Chagraoui et al.
BLOOD (2003)
Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia
TL Reeder et al.
BLOOD (2003)
The forgotten myeloproliferative disorder: Myeloid metaplasia
A Tefferi
ONCOLOGIST (2003)
Plasma matrix metalloproteinase and tissue inhibitor of metalloproteinase in patients with agnogenic myeloid metaplasia or idiopathic primary myelofibrosis
JC Wang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Development of myelofibrosis in mice genetically impaired for GATA-1low expression (GATA-1low mice)
AM Vannucchi et al.
BLOOD (2002)
Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-β (TGF-β) -: Mapping of the OPG promoter region that mediates TGF-β effects
K Thirunavukkarasu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Expression of osteoprotegerin, receptor activator of NF-κB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing
T Kon et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
NF-κB as a central mediator in the induction of TGF-β in monocytes from patients with idiopathic myelofibrosis:: An inflammatory response beyond the realm of homeostasis
P Rameshwar et al.
JOURNAL OF IMMUNOLOGY (2000)
Osteoprotegerin is an αvβ3-induced, NF-κB-dependent survival factor for endothelial cells
UM Malyankar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Medical progress: Myelofibrosis with myeloid metaplasia.
A Tefferi
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
